The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Persimmon Shares Off Despite Profit Surge

Tue, 18th Aug 2015 10:44

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.
----------
FTSE 100 - WINNERS
----------
Shire, up 1.3%. The pharmaceutical company is in the midst of a hostile takeover attempt for US group Baxalta Inc, after the Baxalta board rejected Shire's unsolicited all-share offer earlier this month. Over the weekend, the Financial Times reported Shire Chief Executive Flemming Ornskov has been pressing Shire's case for much of the past fortnight and thinks Baxalta shareholders are open to a deal, citing people close to Shire.

Inmarsat, 0.8%. Shares in the satellite communications company are still benefiting from its announcement on Monday that its third Global Xpress satellite is set to be launched on August 28. Delays to the programme had depressed Inmarsat shares in recent months.
----------
FTSE 100 - LOSERS
----------
Persimmon, down 1.9%. The housebuilder said its pretax profit surged in the first half as it boosted margins, sold more homes and did so at higher prices, all while saying that its performance thus far in the traditionally slower summer selling season still looks robust. But shares were trading lower after multiple analysts said Persimmon's valuation looks stretched. The group said its pretax profit for the six months to the end of June was GBP272.8 million, up from GBP208.9 million a year earlier, as the group's total revenue rose to GBP1.33 billion from GBP1.20 billion and its underlying operating margin rose to 20.5%, a 280 basis point rise year-on-year from 17.7%.

Antofagasta, down 3.0%, BHP Billiton, down 2.8%, Anglo American, down 2.6%, Rio Tinto, down 2.1%. Miners were depressed as the copper price continued to trade near six-year lows.

Weir Group, down 1.9%, Royal Dutch Shell 'A', down 1.8%, Shell 'B', down 1.7%, BP, down 1.3%. Oil companies also were trading lower after the US benchmark West Texas Intermediate oil price fell to a new six-and-a-half year low at USD41.41 a barrel. Brent oil trades at USD48.49 a barrel, down 0.1%.
----------
FTSE 250 - WINNERS
----------
Aldermore, up 2.2%. RBC Capital Markets said it expects "material growth" to be demonstrated by Aldermore's upcoming first-half results, with a 50% rise in net interest income and a more than doubling of the company's adjusted pretax profit year-on-year in the period forecast by RBC.

William Hill, up 1.5%. Numis raised its recommendation on the high-street bookmaker to Buy from Hold, saying it is a "soundly-financed market leader well-placed to weather competition and regulation". "We believe that William Hill is currently in a trough period for financial results as a result of multiple trading and regulatory pressures. But we also believe that earnings momentum and business mix will look more attractive in the first half of 2016," said analyst Ivor Jones.
----------
FTSE 250 - LOSERS
----------
Cairn Energy, down 5.0%. The oil producer said its pretax loss significantly widened in the first half of 2015 as it prepares to spend big in the second half on developing its assets in Senegal and the North Sea. The group posted a pretax loss of USD234.7 million in the first half of 2015, widening from a USD62.1 million loss a year earlier after the company booked an USD177.1 million impairment against its remaining investment in Cairn India, which faces a large Indian tax bill.

John Wood Group, down 2.4%. The oil services company reported a fall in profit in the first half of 2015 as expected, but the company reaffirmed its commitment to grow its dividend and reiterated its full-year outlook remains unchanged. The group posted an expected fall in profit before tax and exceptional items to USD156.3 million in the first half of 2015, compared to a USD182.4 million profit a year earlier as revenue dropped to USD3.06 billion from USD3.80 billion.
----------
AIM ALL-SHARE - WINNERS
----------
Mariana Resources, up 17%. The miner said it has secured a maiden resource estimate for the Hot Maden project in Turkey and said there is no doubt this will increase in the future. The gold and copper project has a total mineral resource estimate of 3.0 million ounces of gold equivalent, comprised of 2.0 million ounces at the indicated level and the remaining balance made up of inferred resources.

ITM Power, up 9.8%. The energy storage and clean fuel company said it has officially launched the RWE gas-to-power plant in Germany it has supplied for RWE Deutschland. "The state-of-the-art plant is part of a new system that, for the first time ever, links together the supply of local electricity, natural gas and district heating," ITM said.
----------
AIM ALL-SHARE - LOSERS
----------
Akers Biosciences, down 18%. The medical devices company posted a widened pretax loss for the first half of 2015, mostly as a result of lower revenue and increased investment in its sales and marketing. For the half year to end-June, the company posted a pretax loss of USD3.4 million, widened from a loss of USD1.1 million a year before, as a result of a fall in revenue to USD1.5 million from USD2.5 million, and a rise in sales and marketing expenses.

APC Technology Group, down 26%. The electronic components supplier said that whilst it expects to meet market expectations for its full-year revenue, its underlying operating profit for the year to end-August will fall below market expectations. APC said that following a detailed project profit margin analysis in its three main operating divisions, it has become clear that margins achieved by its Minimise Energy business have been hit by excessive freight charges and other costs it incurred to meet delivery times on a number of contracts.
----------
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.

Read more
15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

Read more
3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.The AIM-listed firm

Read more
16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants to

Read more
16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea

Read more
10 Jan 2017 12:06

Akers Biosciences to raise $2m in US placing

(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa

Read more
19 Dec 2016 14:52

Akers Biosciences signs three year deal with US hospital group

(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov

Read more
12 Dec 2016 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2016 12:13

Akers Agrees Deal For First Check To Sell Cholesterol Test In US

Read more
10 Nov 2016 09:46

Akers Biosciences gains European patent for ketone breath device

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows

Read more
19 Aug 2016 12:18

Akers Biosciences, ChubeWorkx settle lengthy legal dispute

(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli

Read more
18 Aug 2016 07:22

Akers Says Test Results "Highly Successful" For BreathScan OxiChek

Read more
30 Jun 2016 08:56

Akers Says Rapid Chlamydia Test Trial "Highly Successful"

Read more
27 Jun 2016 08:16

Akers Biosciences Signs First Distribution Deal For BreathScan OxiChek

Read more
26 May 2016 16:27

DIRECTOR DEALINGS: Akers Biosciences Chief Executive Buys First Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.